
Doctors at Spain's Carlos III Hospital in Madrid will test a new vaccine against the Ebola virus from September, Jose Armos Arribas, the Head of the Infection Disease Unit at the hospital confirmed Thursday.
The news comes exactly a year after the Carlos III Hospital was used to treat three Spaniards infected by the virus: missionaries Miguel Pajares and Manuel Garcia Viejo, who contracted the illness in West Africa and nursing auxiliary Teresa Romero, who was infected while treating Garcia Viejo in Madrid.
While Romero recovered from the virus, the missionaries, who were flown to Spain in a serious condition, died.
The new vaccine VSV-ZEBOV has been developed by the World Health Organization and Doctors Without Borders and has already been tested successfully on over 4,000 people in Guinea.
Arribas said the aim of the trails in Spain was to "know more details of the security and the production" of the vaccine, which is based on a virus of non-human origin genetically adapted to stimulate the human organism to produce anti-bodies to the Ebola virus.
Carlos III is also carrying out tests on the serum from a recovered Ebola patient which was used to cure Romero given that the nursing auxiliary received several treatments. It is still uncertain which of those allowed her to overcome the illness.
GMT 18:35 2018 Thursday ,11 January
Syrian refugee sets himself ablaze at UN office in LebanonGMT 18:48 2018 Tuesday ,09 January
Novo Nordisk woos Belgian nano-drug makerGMT 17:54 2017 Wednesday ,27 December
Medical evacuations begin from besieged Syria rebel bastionGMT 12:14 2017 Monday ,25 December
MoHAP successfully conducts cochlear implant operationGMT 18:24 2017 Sunday ,24 December
Palestinian conjoined twins arrive in RiyadhGMT 19:05 2017 Monday ,18 December
new! magazine names fitness & food editorGMT 17:03 2017 Wednesday ,29 November
Spain reports case of 'mad cow disease'GMT 14:05 2017 Saturday ,11 November
EU can't agree on new licence for controversial glyphosate weedkiller
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor